Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2007
10/18/2007US20070243226 Growth factor complex
10/18/2007US20070243209 Compositions and methods for prevention and treatment of fungal diseases
10/18/2007US20070243200 Trehalose producing cells as vaccines
10/18/2007US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine.
10/18/2007US20070243175 Methods and compositions for regenerating tissue
10/18/2007US20070243174 Methods and compositions for directing stem cells to the liver
10/18/2007US20070243173 Methods and compositions for directing stem cells to the heart
10/18/2007US20070243163 Respiratory tract delivery of interferon-tau
10/18/2007CA2849203A1 Glycosylated antibodies
10/18/2007CA2649000A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007CA2648629A1 Marker for predicting graft-versus-host disease and utilization of the same
10/18/2007CA2648330A1 Anti-ccr2 antibody depletes monocytes to treat multiple sclerosis and rheumatoid arthritis
10/18/2007CA2648303A1 5-[monocyclic(hetero)arylsubstituted-1,2,4-oxadliazol-3-yl]-(fused heteroaryl substituted) compounds and their use as s1p1 agonists
10/18/2007CA2647288A1 Glycosylated antibodies
10/18/2007CA2646571A1 Thiazolyl-dihydroquinazolines
10/17/2007EP1845099A1 Artemisine (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same
10/17/2007EP1844784A1 A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
10/17/2007EP1844336A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
10/17/2007EP1844201A2 Aqueous gel formulations containing immune response modifiers
10/17/2007EP1844050A1 Pyrrolopyrimidines useful as inhibitors of protein kinase
10/17/2007EP1844028A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
10/17/2007EP1699398A4 Enhancement of immune responses
10/17/2007EP1482911B1 Water dispersible mixture comprising complex carbohydrates from aloe vera and polyvinylpyrrolidone
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1416916B1 Chitin microparticles and their medical uses
10/17/2007EP1392713B1 Liver x receptor agonists
10/17/2007EP1311289B1 Vaccines containing ribavirin
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007EP1218353B1 Quinazoline derivatives
10/17/2007EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007EP1158990B1 Use of e5564 for the treatment of sepsis by intravenous infusion
10/17/2007EP1075276B1 Adjuvant composition and methods for its use
10/17/2007CN101056979A Anti-histone H1 monoclonal antibody and hybridoma capable of producing the same
10/17/2007CN101056645A Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton
10/17/2007CN101054417A Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
10/17/2007CN101054408A Method for separating housefly secretion type antibacterial peptide, product and application thereof
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053588A Preparation method for compound arabinogalactan film coated tablets
10/17/2007CN101053554A Ginkgolide B powder injection and its preparation method
10/17/2007CN101053400A Oral liquid for male fat reduction
10/17/2007CN101053392A Soluble dietary fiber of konjak
10/17/2007CN101053370A Anti stress immunity enhancing agent for pig
10/17/2007CN101053359A Raspberry health care tea
10/17/2007CN100343282C Hybrid interferon compositions and methods of use
10/17/2007CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007CN100343257C CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease
10/17/2007CN100343254C Pyrrolopyrimidine derivatives
10/17/2007CN100343239C IL-5 inhibiting azauracil pyrimidine derivatives
10/17/2007CN100342880C Oral liquid of royal jelly of ginseng and hairy antler, and preparation method
10/17/2007CN100342865C Shenji ointment and preparing process thereof
10/17/2007CN100342862C Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof
10/17/2007CN100342856C Composition of danazol semisolid skeleton preparation
10/16/2007US7282620 Animal does not develop anaphylaxis, a type I allergy, and specifically induces Arthus reaction, a type III allergy
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007US7282516 CB1, cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007US7282488 Introducing a nucleic acid encoding an agent that increases activated protein C; expressing the agent in the cells; and increasing the APC sufficient to treat the blood vessel.
10/16/2007US7282480 Aqueous sustained-release formulations of proteins
10/16/2007US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening
10/16/2007US7282222 Methods and compositions for directing cells to target organs
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/11/2007WO2007114696A1 Milk oligosaccharides for stimulating the immune system
10/11/2007WO2007114683A1 Milk oligosaccharides for stimulating the immune system
10/11/2007WO2007114262A1 Casein nanoparticle
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007114128A1 Method for production of capsinoid-containing beverage/food
10/11/2007WO2007114013A1 Composition containing lignan compound
10/11/2007WO2007113835A1 Anti-allergy compositions
10/11/2007WO2007113633A2 Immunogenic compositions comprising cat allergen fel dl
10/11/2007WO2007112750A2 Tablets and capsules comprising immunogens for oral administration
10/11/2007WO2007112567A1 Synthetic archaeal glycolipid adjuvants
10/11/2007WO2007085470A3 Cd19-specific immunotoxin and treatment method
10/11/2007WO2007071313A3 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
10/11/2007WO2006109071A8 Vaccine against burkholderia infections
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238728 Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
10/11/2007US20070237785 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007CA2647060A1 Synthetic archaeal glycolipid adjuvants
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842857A1 Mutant interferon proteins and use thereof
10/10/2007EP1842855A2 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
10/10/2007EP1842551A1 E-selectin for treating or preventing stroke
10/10/2007EP1842550A2 Composition for inducing immunotolerance
10/10/2007EP1842549A2 Optimized minigenes and peptides encoded thereby
10/10/2007EP1842431A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
10/10/2007EP1841780A2 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
10/10/2007EP1841743A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841742A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841454A2 Treatment method
1 ... 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 ... 1172